Cellenis®

Cellenis® is globally recognized as the leading provider of a patented platform method to produce Autologous Platelet Rich Plasma (PRP) and other related Cell Therapy technologies for human use. This cutting edge platform technology is distributed under the registered trademark of Cellenis®,processes the patient’s own blood for the purpose of using the platelets, cells and essential proteins for indications in cosmetic medical such as dermatology, aesthetics and more.